Literature DB >> 12649411

Dose reduction of etanercept--can we treat more patients using a fixed budget?

G Clunie, S Voules, R Watts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649411     DOI: 10.1093/rheumatology/keg135

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  1 in total

1.  The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

Authors:  Jan Sørensen; Lis S Andersen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.